Spring til indhold

Health economics and prioritization

Valgfag

This course introduces health systems financing, the development and current state of health care prioritization based on the Danish setting and with perspectives to prioritization settings around the world.

Purpose and description of the course

The need and demand for healthcare always exceeds the funding for health care systems. Hence, there is a need for prioritization between which interventions to introduce and which not to. The challenge lies in arriving at a decision, taking into account the health benefits, costs and opportunity costs, as well as ethical aspects. Decision-makers’ demand for information on the cost-effectiveness of new interventions is increasing around the world with more standardized and more advanced methods being utilized.

This course introduces health systems financing, the development and current state of health care prioritization based on the Danish setting and with perspectives to prioritization settings around the world. The theory and methods used in health economic evaluation will be thoroughly presented and discussed using practical cases. This includes the concepts of quality-adjusted life years (QALY) and decision analytic modelling. Typical challenges faced by life science companies and public decision makers will be analyzed and discussed using real world cases. The participant will get a fundamental understanding of how economic evaluation can contribute to managing public budgets, support new investments and inform product development and market access. Furthermore, the participants will learn to navigate in the prioritization landscape.

The course is relevant for both professionals from the life science sector and the public health care sector. Participants from the life science sector will increase their understanding of the role of health economics in determining the value of medicines and medical technologies. More specifically, participants will understand how public agencies make decisions about market access, how health economic analyses are conducted and how health economics affect decision making in life science product development.

For participants from the public sector the regulation of the health care sector is changing with increased focus on value-based health care and systematic efforts to assess cost-effectiveness. The course will enable participants to engage in this new decision making landscape through an increased understanding of the tools and methods of health economics.
Furthermore, the mixed composition of participants will allow enable networking across sectors and generate a more complete understanding of health economics for both life science and the public healthcare sector.

 

The course has been developed in collaboration with MPG (Master of Public Governance), which is why the course will have participants from both programs.

Your learning outcome

In this course, you will learn:

  • To understand the basics of health systems financing
  • To understand the complex decision problems faced in health care prioritization
  • The theory and practical aspects of measuring health effects including QALY
  • How cost and healthcare resources can be measured and valued
  • The theory and methods used in decision analytic modelling
  • How health economic evaluation can be used to inform decision making

 

Key themes in the course

  • Introduction to health systems financing and health care prioritization
  • Foundation of economic evaluation
  • Measurement and valuation of health effects
  • Cost and healthcare resource use identification, measurement and valuation
  • Decision analytic modeling
  • Prioritization in practice – introduction to different systems and models

 

Who should attend the course

The course is designed for all levels of managers, specialists and analysts from the life science sector and the health care sector who are interested in gaining an understanding of health economic evaluation theory and methods as well as prioritization in practice.

Teachers

Jakob Kjellberg

professor

Jakob Kjellberg

Rasmus wolff

Health Economics Senior Consultant

Rasmus Wolf

Medicinrådet